Literature DB >> 27695003

Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression.

Valerie A Gerriets1, Rigel J Kishton1, Marc O Johnson1,2, Sivan Cohen1, Peter J Siska2, Amanda G Nichols1, Marc O Warmoes3, Aguirre A de Cubas4, Nancie J MacIver5, Jason W Locasale1, Laurence A Turka6, Andrew D Wells7, Jeffrey C Rathmell2.   

Abstract

CD4+ effector T cells (Teff cells) and regulatory T cells (Treg cells) undergo metabolic reprogramming to support proliferation and immunological function. Although signaling via the lipid kinase PI(3)K (phosphatidylinositol-3-OH kinase), the serine-threonine kinase Akt and the metabolic checkpoint kinase complex mTORC1 induces both expression of the glucose transporter Glut1 and aerobic glycolysis for Teff cell proliferation and inflammatory function, the mechanisms that regulate Treg cell metabolism and function remain unclear. We found that Toll-like receptor (TLR) signals that promote Treg cell proliferation increased PI(3)K-Akt-mTORC1 signaling, glycolysis and expression of Glut1. However, TLR-induced mTORC1 signaling also impaired Treg cell suppressive capacity. Conversely, the transcription factor Foxp3 opposed PI(3)K-Akt-mTORC1 signaling to diminish glycolysis and anabolic metabolism while increasing oxidative and catabolic metabolism. Notably, Glut1 expression was sufficient to increase the number of Treg cells, but it reduced their suppressive capacity and Foxp3 expression. Thus, inflammatory signals and Foxp3 balance mTORC1 signaling and glucose metabolism to control the proliferation and suppressive function of Treg cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27695003      PMCID: PMC5215903          DOI: 10.1038/ni.3577

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

1.  TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function.

Authors:  Mukanthu H Nyirenda; Lara Sanvito; Peter J Darlington; Kate O'Brien; Guang-Xian Zhang; Cris S Constantinescu; Amit Bar-Or; Bruno Gran
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

2.  Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.

Authors:  Kui Shin Voo; Laura Bover; Megan Lundell Harline; Jinsheng Weng; Naoshi Sugimoto; Yong-Jun Liu
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

3.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

4.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

5.  Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.

Authors:  Guangyong Peng; Zhong Guo; Yukiko Kiniwa; Kui Shin Voo; Weiyi Peng; Tihui Fu; Daniel Y Wang; Yanchun Li; Helen Y Wang; Rong-Fu Wang
Journal:  Science       Date:  2005-08-26       Impact factor: 47.728

Review 6.  Metabolic control of regulatory T cell development and function.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Trends Immunol       Date:  2014-09-20       Impact factor: 16.687

7.  Tissue adaptation of regulatory and intraepithelial CD4⁺ T cells controls gut inflammation.

Authors:  Tomohisa Sujino; Mariya London; David P Hoytema van Konijnenburg; Tomiko Rendon; Thorsten Buch; Hernandez M Silva; Juan J Lafaille; Bernardo S Reis; Daniel Mucida
Journal:  Science       Date:  2016-06-02       Impact factor: 47.728

8.  Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing.

Authors:  Audrey Nosbaum; Nicolas Prevel; Hong-An Truong; Pooja Mehta; Monika Ettinger; Tiffany C Scharschmidt; Niwa H Ali; Mariela L Pauli; Abul K Abbas; Michael D Rosenblum
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

9.  A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes.

Authors:  Tiffany C Scharschmidt; Kimberly S Vasquez; Hong-An Truong; Sofia V Gearty; Mariela L Pauli; Audrey Nosbaum; Iris K Gratz; Michael Otto; James J Moon; Jan Liese; Abul K Abbas; Michael A Fischbach; Michael D Rosenblum
Journal:  Immunity       Date:  2015-11-17       Impact factor: 31.745

10.  Bcl-6 directly represses the gene program of the glycolysis pathway.

Authors:  Kenneth J Oestreich; Kaitlin A Read; Sarah E Gilbertson; Kenneth P Hough; Paul W McDonald; Veena Krishnamoorthy; Amy S Weinmann
Journal:  Nat Immunol       Date:  2014-09-07       Impact factor: 25.606

View more
  214 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

2.  Immunometabolism: From basic mechanisms to translation.

Authors:  Liza Makowski; Mehdi Chaib; Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 3.  Metabolic Barriers to T Cell Function in Tumors.

Authors:  Ayaka Sugiura; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

4.  mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells.

Authors:  Im-Hong Sun; Min-Hee Oh; Liang Zhao; Chirag H Patel; Matthew L Arwood; Wei Xu; Ada J Tam; Richard L Blosser; Jiayu Wen; Jonathan D Powell
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

Review 5.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 6.  Biochemical Underpinnings of Immune Cell Metabolic Phenotypes.

Authors:  Benjamin A Olenchock; Jeffrey C Rathmell; Matthew G Vander Heiden
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 7.  Differential T-cell receptor signals for T helper cell programming.

Authors:  Penelope A Morel
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

9.  CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism.

Authors:  Hera Wu; DeVon Herr; Nancie J MacIver; Jeffrey C Rathmell; Valerie A Gerriets
Journal:  Int Immunopharmacol       Date:  2020-08-28       Impact factor: 4.932

Review 10.  Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations.

Authors:  Devin M Jones; Kaitlin A Read; Kenneth J Oestreich
Journal:  J Immunol       Date:  2020-10-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.